With a wealth of scientific discovery, Canada is primed to be a global leader in life sciences. To make this a reality, adMare uses its scientific and commercial expertise, specialized infrastructure, and investment capital to build new companies, robust ecosystems and industry-ready talent – and re-invests its returns back into the Canadian industry to ensure it is sustained for the long-term. Our 25+ portfolio companies have attracted more than $1.4 billion of investment, have a combined value of over $3 billion, and employ more than 900 Canadians. Our Innovation Centres are home to 35+ biotech companies, contract research organizations, and specialized commercialization support organizations. The adMare Academy has trained more than 500 alumni – 95% of whom are now working to build our life sciences industry.

Team Members


Claudio Sturino

Sr Director, Head of Chemistry and Pharmaceutical Development


Joseph Mancini

Sr Director, Head of Pharmacology and Biologics


Rabih Kyriakos

Director, Accelerator Program